Sales of Substances Injected into Knee to Treat Osteoarthritis Are Exempt in New York

Tuesday, August 7th, 2012

 
 
Share
Link
New York
General

The New York Department of Taxation and Finance (DTF) recently released an advisory opinion concluding that sales of substances injected into knee to treat osteoarthritis are exempt. N.Y. Advisory Op. of the Commr. of Taxn. and Fin. TSB-A-12(16)S (July 5, 2012).

The taxpayer that petitioned the DTF for the opinion explained how three products--Orthovisc, Euflexxa, and Hyalgan--are used to treat osteoarthritis of the knee. These products are administered by physicians as a series of injections into the knee. A healthy knee is surrounded by a joint fluid that acts as a shock absorber to cushion and protect the knee, but a knee damaged by osteoarthritis has little joint fluid, which causes pain. These products contain hyaluronan or hyaluronic acid (HA), which are naturally derived substances that supplement the knee's fluid, which helps to relieve the pain associated with osteoarthritis. The petitioner asked the DTF whether these products are exempt from sales tax.

New York exempts sales of the following: (1) drugs and medicines intended for use treatment or prevention of illness or disease in human beings; (2) medical equipment (including component parts thereof) and supplies required for such use or to correct or alleviate physical incapacity; and (3) products consumed by humans for the preservation of health. N.Y. Tax Law sec. 1115(a)(3); see also 20 N.Y. Comp. Codes R. and Regs. 528.4[b][3]. The DTF reasoned that when these three substances are injected into the knee, they supplement the knee's fluid, and, thus, improve the operation of the knee, and, thereby, maintain the patient's mobility. Accordingly, the DTF concluded that Orthovisc, Euflexxa, and Hyalgan are exempt because they are products consumed by humans for the preservation of health.

We previously reported on an opinion released by the DTF discussing Synvisc, a product similar to the three discussed in this article. Also note that, although the DTF's opinion did not use these terms, these products are commonly referred to as "viscosupplements," and the related treatment is known as "viscosupplementation."


About TTR

Transaction (buying or selling things), Tax (the tax on this activity), Resources (our people, our website, our support services) - TTR, Inc.

TTR has a website that companies subscribe to and use daily. This website provides a list of everything that can be bought or sold in the U.S. It provides simple answers to whether buying or selling these items is taxable (subject to a sales tax or other tax), and it provides all the legal authority to support these tax answers.

TTR likes to keep things simple and fun, which is why it has great people who provide help to clients on any support questions they have about transaction tax issues.

Please visit TTR on the web at www.ttrus.com or call 866.578.8193.

Texas Releases Detailed Guidance on Exempt Organizations

Thursday, October 18th, 2018 -The Texas Comptroller has released a publication that provides detailed information on how sales and use tax a...

Telephone Answering Services Taxable in Arkansas

Tuesday, October 16th, 2018 -The Arkansas Department of Finance and Administration recently ruled that the service of answering calls on be...

Washington Provides Guidance on Lodging Tax for Online...

Friday, October 12th, 2018 -The Washington Department of Revenue released updated guidance that provides tax reporting information for bed...

Economic Nexus in West Virginia

Wednesday, October 10th, 2018 -The West Virginia State Tax Department announced that it will require remote sellers to begin collecting sales...

Idaho Provides Guidance on the Exemption for Medical...

Monday, October 8th, 2018 -The Idaho State Tax Commission recently released guidance that explains Idaho's sales and use tax laws for buy...

Arkansas Does Not Follow Federal Law on Foreign Income

Friday, October 5th, 2018 -The Arkansas Department of Taxation and Finance recently released an opinion that says the state does not conf...